Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: CollPlant Biotech(CLGN) the Revenue is 73 K (-96.45%);the EBIT is -3.115 M (-89.02%);the EPS is -2.25 (-1677%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B96.45%
----
----
EBIT
-0.00B89.02%
----
----
EPS
-2.25281677.21%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf